Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

Epidemiology

Parity, breastfeeding, and the risk of early-onset breast cancer in women with a BRCA1 pathogenic variant

Abstract

Background

It is not clear if breastfeeding and/or parity are associated with the risk of breast cancer among women with a germline pathogenic variant in BRCA1. We sought to evaluate the associations of these two factors with early-onset breast cancer in the BRCA1 pathogenic variant.

Methods

This case-control study included individuals with a BRCA1 pathogenic variant enroled in a longitudinal study using reproductive and disease histories ascertained at the time of enrolment. Cases had invasive breast cancer prior to age 45, and controls had no breast cancer prior to age 45. Logistic regression was used to evaluate the associations of parity and breastfeeding with cancer risk.

Results

Parity per se was not associated with breast cancer risk (OR = 1.09; 95%CI 0.95–1.25); however, among women who never breastfed, the OR for parous vs. nulliparous women was 1.45 (95%CI 1.20–1.75). After matching for parity, ever breastfeeding was associated with 25% lower odds of breast cancer (95%CI 0.61–0.91), and the odds ratio was 0.53 (95%CI 0.40–0.72) for those who breastfed for 20 or more months.

Discussion

Our findings suggest a potential role for breastfeeding in the prevention of young-onset breast cancer among individuals with a BRCA1 pathogenic variant and provide insight into possible prevention targets.

This is a preview of subscription content, access via your institution

Access options

Buy this article

USD 39.95

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

Data availability

All data is original, and consent was not obtained from participants to make data externally available.

References

  1. Kuchenbaecker KB, Hopper JL, Barnes DR, Phillips KA, Mooij TM, Roos-Blom MJ, et al. Risks of breast, ovarian, and contralateral breast cancer for BRCA1 and BRCA2 mutation carriers. JAMA. 2017;317:2402–16.

    Article  CAS  PubMed  Google Scholar 

  2. Mavaddat N, Barrowdale D, Andrulis IL, Domchek SM, Eccles D, Nevanlinna H, et al. Pathology of breast and ovarian cancers among BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA). Cancer Epidemiol Biomark Prev. 2012;21:134–47.

    Article  CAS  Google Scholar 

  3. Hartmann LC, Schaid DJ, Woods JE, Crotty TP, Myers JL, Arnold PG, et al. Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer. N. Engl J Med. 1999;340:77–84.

    Article  CAS  PubMed  Google Scholar 

  4. Nolan E, Vaillant F, Branstetter D, Pal B, Giner G, Whitehead L, et al. RANK ligand as a potential target for breast cancer prevention in BRCA1-mutation carriers. Nat Med. 2016;22:933–9.

    Article  CAS  PubMed  Google Scholar 

  5. Lim E, Vaillant F, Wu D, Forrest NC, Pal B, Hart AH, et al. Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriers. Nat Med. 2009;15:907–13.

    Article  CAS  PubMed  Google Scholar 

  6. Groelly FJ, Fawkes M, Dagg RA, Blackford AN, Tarsounas M. Targeting DNA damage response pathways in cancer. Nat Rev Cancer. 2023;23:78–94.

    Article  CAS  PubMed  Google Scholar 

  7. Lukasiewicz S, Czeczelewski M, Forma A, Baj J, Sitarz R, Stanislawek A. Breast cancer-epidemiology, risk factors, classification, prognostic markers, and current treatment strategies-an updated review. Cancers. 2021;13:4287.

  8. Stordal B. Breastfeeding reduces the risk of breast cancer: a call for action in high-income countries with low rates of breastfeeding. Cancer Med. 2023;12:4616–25.

    Article  PubMed  Google Scholar 

  9. Nichols HB, Schoemaker MJ, Cai J, Xu J, Wright LB, Brook MN, et al. Breast cancer risk after recent childbirth: a pooled analysis of 15 prospective studies. Ann Intern Med. 2019;170:22–30.

    Article  PubMed  Google Scholar 

  10. Faermann R, Friedman E, Kaidar-Person O, Brodsky M, Neiman OH, Shalmon A, et al. Pregnancy associated breast cancer among Israeli BRCA1/BRCA2 carriers in a high-risk clinic. Acad Radio. 2023;30:248–54.

    Article  Google Scholar 

  11. Kotsopoulos J, Lubinski J, Salmena L, Lynch HT, Kim-Sing C, Foulkes WD, et al. Breastfeeding and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers. Breast Cancer Res. 2012;14:R42.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Cullinane CA, Lubinski J, Neuhausen SL, Ghadirian P, Lynch HT, Isaacs C, et al. Effect of pregnancy as a risk factor for breast cancer in BRCA1/BRCA2 mutation carriers. Int J Cancer. 2005;117:988–91.

    Article  CAS  PubMed  Google Scholar 

  13. Marquis ST, Rajan JV, Wynshaw-Boris A, Xu J, Yin GY, Abel KJ, et al. The developmental pattern of Brca1 expression implies a role in differentiation of the breast and other tissues. Nat Genet. 1995;11:17–26.

    Article  CAS  PubMed  Google Scholar 

  14. Russo J, Lynch H, Russo IH. Mammary gland architecture as a determining factor in the susceptibility of the human breast to cancer. Breast J. 2001;7:278–91.

    Article  CAS  PubMed  Google Scholar 

  15. Poole AJ, Li Y, Kim Y, Lin SC, Lee WH, Lee EY. Prevention of Brca1-mediated mammary tumorigenesis in mice by a progesterone antagonist. Science. 2006;314:1467–70.

    Article  CAS  PubMed  Google Scholar 

  16. Jernstrom H, Johannsson O, Borg A, Olsson H. Do BRCAl mutations affect the ability to breast-feed? Significantly shorter length of breast-feeding among BRCAl mutation carriers compared with their unaffected relatives. Breast. 1998;7:320–4.

  17. Rios AC, Fu NY, Jamieson PR, Pal B, Whitehead L, Nicholas KR, et al. Essential role for a novel population of binucleated mammary epithelial cells in lactation. Nat Commun. 2016;7:11400.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. He Z, Ghorayeb R, Tan S, Chen K, Lorentzian AC, Bottyan J, et al. Pathogenic BRCA1 variants disrupt PLK1-regulation of mitotic spindle orientation. Nat Commun. 2022;13:2200.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Lechler T, Fuchs E. Asymmetric cell divisions promote stratification and differentiation of mammalian skin. Nature. 2005;437:275–80.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Hannan FM, Elajnaf T, Vandenberg LN, Kennedy SH, Thakker RV. Hormonal regulation of mammary gland development and lactation. Nat Rev Endocrinol. 2023;19:46–61.

    Article  PubMed  Google Scholar 

  21. Tworoger SS, Eliassen AH, Zhang X, Qian J, Sluss PM, Rosner BA, et al. A 20-year prospective study of plasma prolactin as a risk marker of breast cancer development. Cancer Res. 2013;73:4810–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Tworoger SS, Hankinson SE. Prolactin and breast cancer etiology: an epidemiologic perspective. J Mammary Gland Biol Neoplasia. 2008;13:41–53.

    Article  PubMed  Google Scholar 

  23. Tikk K, Sookthai D, Johnson T, Dossus L, Clavel-Chapelon F, Tjønneland A, et al. Prolactin determinants in healthy women: a large cross-sectional study within the EPIC cohort. Cancer Epidemiol Biomark Prev. 2014;23:2532–42.

    Article  CAS  Google Scholar 

  24. Fortner RT, Sisti J, Chai B, Collins LC, Rosner B, Hankinson SE, et al. Parity, breastfeeding, and breast cancer risk by hormone receptor status and molecular phenotype: results from the Nurses’ Health Studies. Breast Cancer Res. 2019;21:40.

    Article  PubMed  PubMed Central  Google Scholar 

  25. Islami F, Liu Y, Jemal A, Zhou J, Weiderpass E, Colditz G, et al. Breastfeeding and breast cancer risk by receptor status-a systematic review and meta-analysis. Ann Oncol. 2015;26:2398–407.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Terry MB, Liao Y, Kast K, Antoniou AC, McDonald JA, Mooij TM, et al. The influence of number and timing of pregnancies on breast cancer risk for women with BRCA1 or BRCA2 mutations. JNCI Cancer Spectr. 2018;2:pky078.

    Article  PubMed  Google Scholar 

  27. Jernstrom H, Lubinski J, Lynch HT, Ghadirian P, Neuhausen S, Isaacs C, et al. Breast-feeding and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers. J Natl Cancer Inst. 2004;96:1094–8.

    Article  CAS  PubMed  Google Scholar 

  28. Tomeo CA, Rich-Edwards JW, Michels KB, Berkey CS, Hunter DJ, Frazier AL, et al. Reproducibility and validity of maternal recall of pregnancy-related events. Epidemiology. 1999;10:774–7.

    Article  CAS  PubMed  Google Scholar 

  29. Troy LM, Michels KB, Hunter DJ, Spiegelman D, Manson JE, Colditz GA, et al. Self-reported birthweight and history of having been breastfed among younger women: an assessment of validity. Int J Epidemiol. 1996;25:122–7.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We are grateful for the contributions of the women who participated in this study, without whom this research would not be possible. We acknowledge the study staff, students, and volunteers who assisted with data collection and data entry: Ellen MacDougall, Shana Kim, Clotilde Ngwa, Aiman Fatima, Rebecca Raj, Pooja Chaudhary, Pooja Patel, Suvetha Krishnapillai, Banafsheh Mesbahi, Angela Cheriyan, Anasua Kundu, Nurun Nahar, Abigail Sims, Alexandra Parco, Christine Zhu, Cindy Zhang, Elizabeth Hall, Lisa Asbroek, Izzar Linares, Shaelyn Laurie, Kamrun Urmi, Amina Mahmood, Mayra Gholizadeh, Nazia Awan, Neelam Dehal, Yasmin Tehrani, Jasdeep Brar, Marsela Supriadi, Jenani Anantharajah, Grace Li, Hannah Horvath, Laavanya Somasundaram, Anne Matip, Forough Armaghan, Mohamed Bekkouche, Yasaman Ghazi, Qadriy Naimi, Miao Jia, Li Quan, Angelo Wang, Baker Hawa, Bhakti Almoula, Bhumi Patel, Brynne Stewart, Charlotte Francis, Cynthia (Chen) Ji, Fabiah Mahmood, Fahmida Rahman, Jasdeep Brar, Jenani Anantharajah, Jie Zhaung, Leila Gayo, Liao Jia, Madeline Firmanto, Matthew Gertig, Mayra Robalino, Rachel Trister, Sheena Sajan, Sukhnit Kandola, Martina Delle Marchette, Serena Negri, Cristina Dell’Oro, Alessandra Inzoli, Rosa Alfonso, Consol Lopez and Francesco Cusco.

Funding

Joanne Kotsopoulos is a recipient of a Tier II Canada Research Chair. Steven A. Narod is the recipient of a Tier I Canada Research Chair. Charis Eng is the Sondra J. and Stephen R. Hardis Endowed Chair of Cancer Genomic Medicine at the Cleveland Clinic. This work was supported by a Canadian Cancer Society Research Institute grant (703058), a Terry Fox Program Project grant (TFP-185032), the Peter Gilgan Foundation, and a Contract 194751-2017 from Norwegian Cancer Society. Funding supported the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.

Author information

Authors and Affiliations

Authors

Consortia

Contributions

Study conception, study design, and methodology (SAN, JK, CM). Funding acquisition (SAN, JK). Data curation (SAN, JK, PS). Formal analysis (PS, SN, JK). Drafting of manuscript (SAN, JK, CS). Data contribution (JK, CAM, JL, TH, RHK, NT, AE, WF, AA, SLN, LB, RK, TP, BK, RF, FC, PS, JG, SAN). Review and editing of manuscript (JK, CAM, JL, TH, RHK, NT, AE, WF, AA, SLN, LB, RK, TP, BK, RF, FC, PS, JG, SAN).

Corresponding author

Correspondence to Steven A. Narod.

Ethics declarations

Competing interests

The authors declare no competing interests.

Ethics approval and consent to participate

This study was approved by the Research Ethics Board at Women’s College Hospital, and consent was obtained from participants. The study was performed in accordance with the Declaration of Helsinki.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kotsopoulos, J., Maxwell, C.A., Lubinski, J. et al. Parity, breastfeeding, and the risk of early-onset breast cancer in women with a BRCA1 pathogenic variant. Br J Cancer 133, 104–110 (2025). https://doi.org/10.1038/s41416-025-03029-x

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Version of record:

  • Issue date:

  • DOI: https://doi.org/10.1038/s41416-025-03029-x

Search

Quick links